news
Click to download PDF or view news articles.
Xconomy website by Luke Timmerman. Allozyne, Developer of Multiple Sclerosis Drug in Few Shots, Poised to Enter Clinical Trials (Oct 16, 2008)
Seattle Times: Local Biotechs Search for Savvy CEOs (April 8, 2008)
Seattle Business Magazine: 8 in 2008, Up and coming Seattle Businesses (January 2008)
Bio Weekly: BioTech Allozyne Improving Protien Drugs with $30M Round (Oct 29, 2007)
Puget Sound Business Journal: Allozyne lands $30M, hires veteran as CEO (Oct 26, 2007)
Seattle Times: In 2nd Round, Biotech startup Allozyne nets $30M (Oct 26, 2007)